Inspire Medical Systems (NASDAQ:INSP) issued its quarterly earnings data on Tuesday, May 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.39) by $0.04, Briefing.com reports. The business had revenue of $16.30 million during the quarter, compared to analysts’ expectations of $17.79 million. The company’s revenue was up 63.0% compared to the same quarter last year.
Inspire Medical Systems stock opened at $55.10 on Friday. Inspire Medical Systems has a fifty-two week low of $27.30 and a fifty-two week high of $64.34.
In related news, CEO Timothy P. Herbert sold 15,000 shares of the company’s stock in a transaction on Tuesday, March 19th. The shares were sold at an average price of $56.47, for a total value of $847,050.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Marilyn C. Nelson sold 152,985 shares of the company’s stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $51.66, for a total transaction of $7,903,205.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 403,506 shares of company stock worth $21,465,059.
A number of brokerages have recently issued reports on INSP. Zacks Investment Research cut Inspire Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, March 5th. Dougherty & Co assumed coverage on Inspire Medical Systems in a research note on Tuesday, February 5th. They issued a “buy” rating and a $64.00 target price on the stock.
ILLEGAL ACTIVITY NOTICE: “Inspire Medical Systems (NASDAQ:INSP) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS” was published by Rockland Register and is owned by of Rockland Register. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://rocklandregister.com/2019/05/31/inspire-medical-systems-insp-releases-quarterly-earnings-results-beats-estimates-by-0-04-eps.html.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
See Also: What is a dead cat bounce?
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.